NxStage Medical Company Profile (NASDAQ:NXTM)

About NxStage Medical

NxStage Medical logoNxStage Medical, Inc. is a medical technology company. The Company is engaged in the development, manufacturing and marketing of products and services for patients suffering from chronic or acute kidney failure. The Company operates through three segments: System One, In-Center and Services. It offers its products and services to various markets, such as home, critical care and in-center. The System One segment is engaged in the sale and rental of the System One and PureFlow SL dialysate preparation equipment, and the sale of disposable products in the home and critical care markets. The In-Center segment is engaged in the sale of blood tubing sets and needles for hemodialysis, primarily for the treatment of end-stage renal disease (ESRD) patients at dialysis clinics, and needles for apheresis. The Services segment offers dialysis services provided to patients at its NxStage Kidney Care dialysis centers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: NXTM
  • CUSIP: 67072V10
Key Metrics:
  • Previous Close: $29.37
  • 50 Day Moving Average: $26.924
  • 200 Day Moving Average: $24.856
  • 52-Week Range: $64,756,000.00 - $13.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 978.83
  • P/E Growth: -18.440
  • Market Cap: $1.90B
  • Outstanding Shares: 64,756,000
  • Beta: 0.37
Profitability:
  • Net Margins: -1.61%
  • Return on Equity: -2.97%
  • Return on Assets: -1.87%
Debt:
  • Debt-to-Equity Ratio: 0.01%
  • Current Ratio: 2.97%
  • Quick Ratio: 2.00%
Additional Links:
Companies Related to NxStage Medical:

Analyst Ratings

Consensus Ratings for NxStage Medical (NASDAQ:NXTM) (?)
Ratings Breakdown: 1 Sell Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $30.80 (4.89% upside)

Analysts' Ratings History for NxStage Medical (NASDAQ:NXTM)
Show:
DateFirmActionRatingPrice TargetDetails
2/6/2017Jefferies Group LLCBoost Price TargetBuy$38.00View Rating Details
1/23/2017Canaccord GenuitySet Price TargetBuy$31.00View Rating Details
12/16/2016Northland SecuritiesSet Price TargetBuy$25.00 -> $35.00View Rating Details
8/7/2016BTIG ResearchReiterated RatingBuy$29.00View Rating Details
6/3/2016Piper Jaffray CompaniesReiterated RatingBuy$21.00View Rating Details
5/5/2016Wells Fargo & CompanyReiterated RatingSellView Rating Details
12/11/2015Sterne Agee CRTInitiated CoverageBuyView Rating Details
11/4/2015Leerink SwannBoost Price Target$24.00 -> $30.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for NxStage Medical (NASDAQ:NXTM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017        
8/4/2016Q216($0.04)($0.03)$89.44 million$92.20 millionViewN/AView Earnings Details
5/4/2016Q116($0.05)($0.02)$88.40 million$89.20 millionViewListenView Earnings Details
2/10/2016Q415($0.04)($0.04)$86.83 million$89.80 millionViewListenView Earnings Details
11/3/2015Q315($0.08)($0.03)$82.06 million$86.50 millionViewN/AView Earnings Details
8/6/2015Q215($0.10)($0.08)$79.89 million$80.30 millionViewListenView Earnings Details
5/6/2015Q115($0.11)($0.09)$77.92 million$79.50 millionViewListenView Earnings Details
2/26/2015Q414($0.10)($0.08)$75.75 million$79.90 millionViewListenView Earnings Details
11/6/2014Q3($0.13)($0.11)$71.83 million$75.30 millionViewN/AView Earnings Details
8/7/2014Q214($0.11)($0.12)$70.52 million$74.10 millionViewN/AView Earnings Details
5/8/2014Q114($0.11)($0.09)$69.44 million$72.20 millionViewN/AView Earnings Details
2/27/2014Q413($0.09)($0.08)$67.66 million$69.40 millionViewN/AView Earnings Details
11/7/2013Q313$0.22($0.08)$124.03 million$66.90 millionViewListenView Earnings Details
7/25/2013Q2 2013($0.07)($0.06)$64.66 million$65.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013($0.08)($0.08)$61.14 million$61.60 millionViewN/AView Earnings Details
2/28/2013Q4 2012($0.05)($0.04)$63.54 million$65.00 millionViewN/AView Earnings Details
11/8/2012Q312($0.06)($0.04)$60.90 million$61.00 millionViewN/AView Earnings Details
8/8/2012($0.09)($0.09)ViewN/AView Earnings Details
5/8/2012($0.09)($0.09)ViewN/AView Earnings Details
2/29/2012($0.09)($0.08)ViewN/AView Earnings Details
11/3/2011($0.10)($0.10)ViewN/AView Earnings Details
8/3/2011($0.10)($0.10)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NxStage Medical (NASDAQ:NXTM)
Current Year EPS Consensus Estimate: $-0.080 EPS
Next Year EPS Consensus Estimate: $0.030 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.06)($0.04)($0.05)
Q2 20164($0.07)($0.04)($0.05)
Q3 20165($0.04)$0.01($0.02)
Q4 20164($0.03)$0.00($0.02)
Q1 20172($0.01)($0.01)($0.01)
Q2 20172$0.00$0.00$0.00
Q3 20173$0.00$0.01$0.01
Q4 20173$0.00$0.03$0.02
Q1 20181$0.04$0.04$0.04
Q2 20181$0.05$0.05$0.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NxStage Medical (NASDAQ:NXTM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NxStage Medical (NASDAQ:NXTM)
Insider Ownership Percentage: 4.70%
Institutional Ownership Percentage: 97.26%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/15/2017Winifred L SwanSVPSell16,049$28.01$449,532.49View SEC Filing  
2/14/2017Robert S BrownInsiderSell2,448$28.28$69,229.44View SEC Filing  
2/10/2017Joseph E Turk JrPresidentSell3,500$28.36$99,260.00View SEC Filing  
2/8/2017Robert S BrownInsiderSell3,054$27.61$84,320.94View SEC Filing  
2/7/2017Robert S BrownInsiderSell3,117$27.54$85,842.18View SEC Filing  
2/6/2017Robert S BrownInsiderSell16,283$26.87$437,524.21View SEC Filing  
2/2/2017Joseph E Turk JrPresidentSell15,669$26.19$410,371.11View SEC Filing  
2/2/2017Robert S BrownInsiderSell37,347$26.68$996,417.96View SEC Filing  
1/26/2017Robert S BrownInsiderSell42,000$26.05$1,094,100.00View SEC Filing  
1/23/2017Robert S BrownInsiderSell21,615$26.20$566,313.00View SEC Filing  
1/20/2017Matthew W TowseSVPSell4,300$26.19$112,617.00View SEC Filing  
1/18/2017Jeffrey H BurbankCEOSell7,500$27.63$207,225.00View SEC Filing  
1/18/2017Robert S BrownInsiderSell8,183$27.58$225,687.14View SEC Filing  
1/17/2017Jeffrey H BurbankCEOSell7,500$27.52$206,400.00View SEC Filing  
1/17/2017Robert S BrownInsiderSell10,805$27.72$299,514.60View SEC Filing  
1/13/2017Joseph E Turk JrPresidentSell7,500$28.00$210,000.00View SEC Filing  
1/11/2017Joseph E Turk JrPresidentSell1,000$27.77$27,770.00View SEC Filing  
12/20/2016Matthew W TowseSVPSell4,300$25.55$109,865.00View SEC Filing  
12/15/2016Winifred L SwanSVPSell3,500$25.91$90,685.00View SEC Filing  
12/14/2016Jeffrey H BurbankCEOSell7,500$25.68$192,600.00View SEC Filing  
12/13/2016Jeffrey H BurbankCEOSell7,500$25.42$190,650.00View SEC Filing  
12/13/2016Joseph E Turk JrPresidentSell1,000$25.42$25,420.00View SEC Filing  
11/28/2016Joseph E Turk JrPresidentSell12,169$26.01$316,515.69View SEC Filing  
11/23/2016Jeffrey H BurbankCEOSell7,500$24.01$180,075.00View SEC Filing  
11/22/2016Jeffrey H BurbankCEOSell7,500$25.51$191,325.00View SEC Filing  
11/22/2016Winifred L SwanSVPSell3,000$25.51$76,530.00View SEC Filing  
11/21/2016Daniel A GianniniDirectorSell6,449$25.96$167,416.04View SEC Filing  
11/21/2016Matthew W TowseSVPSell4,300$26.23$112,789.00View SEC Filing  
11/17/2016Joseph E Turk JrPresidentSell1,000$25.97$25,970.00View SEC Filing  
11/16/2016Joseph E Turk JrPresidentSell22,500$26.26$590,850.00View SEC Filing  
9/14/2016Craig W MooreDirectorSell3,000$23.31$69,930.00View SEC Filing  
5/12/2016Joseph E Turk JrPresidentSell1,500$17.89$26,835.00View SEC Filing  
5/10/2016Joseph E Turk JrPresidentSell1,057$18.00$19,026.00View SEC Filing  
4/21/2016Joseph E Turk JrPresidentSell2,000$15.73$31,460.00View SEC Filing  
4/14/2016Winifred L SwanSVPSell6,260$16.40$102,664.00View SEC Filing  
4/5/2016Joseph E Turk JrPresidentSell2,500$15.05$37,625.00View SEC Filing  
3/22/2016Joseph E Turk JrPresidentSell2,000$14.34$28,680.00View SEC Filing  
3/14/2016Winifred L SwanSVPSell620$15.69$9,727.80View SEC Filing  
3/10/2016Joseph E Turk JrPresidentSell2,500$15.58$38,950.00View SEC Filing  
2/24/2016Barry M StraubeDirectorBuy1,500$14.20$21,300.00View SEC Filing  
2/24/2016Joseph E Turk JrPresidentSell2,992$14.12$42,247.04View SEC Filing  
2/16/2016Winifred L. SwanSVPSell2,500$14.07$35,175.00View SEC Filing  
2/12/2016Earl R. LewisDirectorBuy21,000$14.63$307,230.00View SEC Filing  
2/10/2016Joseph E. Turk, Jr.PresidentSell991$16.25$16,103.75View SEC Filing  
2/9/2016Joseph E. Turk, Jr.PresidentSell2,500$16.88$42,200.00View SEC Filing  
2/4/2016Joseph E. Turk, Jr.PresidentSell991$19.60$19,423.60View SEC Filing  
1/20/2016Joseph E Turk JrPresidentSell2,000$18.75$37,500.00View SEC Filing  
1/14/2016Winifred L. SwanSVPSell620$19.04$11,804.80View SEC Filing  
1/11/2016Matthew W. TowseSVPSell3,472$20.40$70,828.80View SEC Filing  
1/8/2016Joseph E. Turk, Jr.PresidentSell1,500$21.03$31,545.00View SEC Filing  
1/7/2016Joseph E. Turk, Jr.PresidentSell3,713$20.78$77,156.14View SEC Filing  
12/22/2015Joseph E. Turk, Jr.PresidentSell5,000$20.92$104,600.00View SEC Filing  
12/16/2015Joseph E. Turk, Jr.PresidentSell800$19.99$15,992.00View SEC Filing  
12/15/2015Matthew W. TowseSVPSell2,863$19.51$55,857.13View SEC Filing  
12/14/2015Winifred L. SwanSVPSell2,500$18.90$47,250.00View SEC Filing  
12/10/2015Jeffrey H. BurbankCEOSell9,274$18.94$175,649.56View SEC Filing  
12/8/2015Joseph E. Turk, Jr.PresidentSell2,913$19.38$56,453.94View SEC Filing  
11/20/2015Craig W MooreDirectorSell1,000$20.00$20,000.00View SEC Filing  
11/19/2015Joseph E Turk JrPresidentSell2,000$19.65$39,300.00View SEC Filing  
11/18/2015Craig W MooreDirectorSell4,000$19.60$78,400.00View SEC Filing  
11/16/2015Winifred L. SwanSVPSell2,500$19.65$49,125.00View SEC Filing  
11/12/2015Joseph E. Turk, Jr.PresidentSell4,055$20.44$82,884.20View SEC Filing  
11/10/2015Jeffrey H. BurbankCEOSell10,000$20.75$207,500.00View SEC Filing  
11/10/2015Joseph E. Turk, Jr.PresidentSell7,500$21.03$157,725.00View SEC Filing  
11/10/2015Matthew W. TowseSVPSell2,863$20.32$58,176.16View SEC Filing  
11/9/2015Daniel A GianniniDirectorSell6,593$20.30$133,837.90View SEC Filing  
11/9/2015Jeffrey H. BurbankCEOSell10,000$20.32$203,200.00View SEC Filing  
11/4/2015Joseph E. Turk, Jr.PresidentSell4,826$19.62$94,686.12View SEC Filing  
11/4/2015Matthew W. TowseSVPSell8,591$19.50$167,524.50View SEC Filing  
11/3/2015Robert S. BrowninsiderSell44,400$19.00$843,600.00View SEC Filing  
10/20/2015Joseph E. Turk, Jr.PresidentSell2,000$15.80$31,600.00View SEC Filing  
10/16/2015Jeffrey H. BurbankCEOSell10,000$15.59$155,900.00View SEC Filing  
10/15/2015Jeffrey H. BurbankCEOSell10,000$14.98$149,800.00View SEC Filing  
10/14/2015Winifred L. SwanSVPSell2,500$15.46$38,650.00View SEC Filing  
10/8/2015Joseph E. Turk, Jr.PresidentSell2,839$15.42$43,777.38View SEC Filing  
9/24/2015Joseph E Turk JrPresidentSell2,000$17.26$34,520.00View SEC Filing  
9/17/2015Jeffrey H. BurbankCEOSell10,000$16.18$161,800.00View SEC Filing  
9/16/2015Jeffrey H. BurbankCEOSell10,000$15.99$159,900.00View SEC Filing  
9/15/2015Craig W MooreDirectorSell1,000$16.00$16,000.00View SEC Filing  
9/14/2015Winifred L. SwanSVPSell2,500$16.01$40,025.00View SEC Filing  
9/9/2015Joseph E. Turk, Jr.PresidentSell2,839$16.54$46,957.06View SEC Filing  
8/25/2015Joseph E Turk JrPresidentSell2,000$18.25$36,500.00View SEC Filing  
8/17/2015Robert S BrownInsiderSell10,825$18.30$198,097.50View SEC Filing  
8/14/2015Winifred L SwanSVPSell2,500$18.14$45,350.00View SEC Filing  
8/13/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
8/12/2015Jeffrey H BurbankCEOSell10,000$18.03$180,300.00View SEC Filing  
8/12/2015Joseph E Turk JrPresidentSell3,252$17.74$57,690.48View SEC Filing  
7/22/2015Joseph E Turk JrPresidentSell2,000$13.86$27,720.00View SEC Filing  
7/14/2015Winifred L SwanSVPSell2,500$14.71$36,775.00View SEC Filing  
6/23/2015Joseph E Turk JrPresidentSell2,000$15.36$30,720.00View SEC Filing  
6/18/2015Jeffrey H BurbankCEOSell20,000$15.56$311,200.00View SEC Filing  
6/15/2015Winifred L SwanSVPSell2,500$15.48$38,700.00View SEC Filing  
6/10/2015Joseph E Turk JrPresidentSell2,839$16.00$45,424.00View SEC Filing  
5/18/2015Winifred L SwanSVPSell2,500$16.65$41,625.00View SEC Filing  
5/12/2015Jeffrey H BurbankCEOSell10,000$16.44$164,400.00View SEC Filing  
4/21/2015Joseph E Turk JrPresidentSell1,950$18.40$35,880.00View SEC Filing  
4/17/2015Jeffrey H BurbankCEOSell10,000$18.08$180,800.00View SEC Filing  
4/16/2015Jeffrey H BurbankCEOSell10,000$18.31$183,100.00View SEC Filing  
4/8/2015Joseph E Turk JrPresidentSell1,500$18.34$27,510.00View SEC Filing  
3/26/2015Joseph E Turk JrPresidentSell1,150$16.94$19,481.00View SEC Filing  
3/18/2015Jeffrey H BurbankCEOSell20,000$17.40$348,000.00View SEC Filing  
3/10/2015Joseph E Turk JrPresidentSell1,500$16.44$24,660.00View SEC Filing  
2/25/2015Joseph E Turk JrPresidentSell2,082$17.88$37,226.16View SEC Filing  
1/27/2015Joseph E Turk JrPresidentSell2,350$18.70$43,945.00View SEC Filing  
1/14/2015Winifred L SwanSVPSell500$18.44$9,220.00View SEC Filing  
1/13/2015Joseph E Turk JrPresidentSell1,500$18.35$27,525.00View SEC Filing  
1/13/2015Winifred L SwanSVPSell666$18.35$12,221.10View SEC Filing  
12/29/2014Winifred L SwanSVPSell667$18.17$12,119.39View SEC Filing  
12/23/2014Joseph E Turk JrPresidentSell2,350$18.44$43,334.00View SEC Filing  
12/15/2014Joseph E Turk JrPresidentSell2,000$17.45$34,900.00View SEC Filing  
12/15/2014Kevin HershbergerCAOSell8,000$17.19$137,520.00View SEC Filing  
12/10/2014Joseph E Turk JrPresidentSell1,500$17.77$26,655.00View SEC Filing  
12/5/2014Jeffrey H BurbankCEOSell5,000$17.16$85,800.00View SEC Filing  
12/2/2014Robert S BrownInsiderSell34,700$17.44$605,168.00View SEC Filing  
12/1/2014Joseph E Turk JrPresidentSell24,762$17.04$421,944.48View SEC Filing  
12/1/2014Winifred L SwanSVPSell16,667$17.04$284,005.68View SEC Filing  
11/25/2014Joseph E Turk JrPresidentSell3,350$17.59$58,926.50View SEC Filing  
11/14/2014Joseph E Turk JrPresidentSell29,560$17.39$514,048.40View SEC Filing  
11/14/2014Winifred L SwanSVPSell17,167$17.37$298,190.79View SEC Filing  
11/12/2014Joseph E Turk JrPresidentSell26,261$16.27$427,266.47View SEC Filing  
11/12/2014Kevin HershbergerCAOSell11,056$16.58$183,308.48View SEC Filing  
11/7/2014Joseph E Turk JrPresidentSell24,761$16.25$402,366.25View SEC Filing  
11/3/2014Joseph E Turk JrPresidentSell5,717$15.50$88,613.50View SEC Filing  
10/23/2014Joseph E Turk JrPresidentSell3,550$14.55$51,652.50View SEC Filing  
10/23/2014Robert S BrownInsiderSell45,370$14.53$659,226.10View SEC Filing  
9/24/2014Joseph E Turk JrPresidentSell3,550$13.34$47,357.00View SEC Filing  
9/19/2014Jeffrey H BurbankCEOSell2,416$14.00$33,824.00View SEC Filing  
9/19/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
9/10/2014Kevin HershbergerCAOSell843$13.58$11,447.94View SEC Filing  
9/8/2014Jeffrey H BurbankCEOSell2,322$14.00$32,508.00View SEC Filing  
9/8/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
8/27/2014Joseph E Turk JrPresidentSell2,550$13.06$33,303.00View SEC Filing  
8/15/2014Winifred L SwanSVPSell2,500$13.60$34,000.00View SEC Filing  
8/7/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
8/7/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
7/24/2014Joseph E Turk JrPresidentSell3,550$13.50$47,925.00View SEC Filing  
7/18/2014Winifred L SwanSVPSell2,000$13.46$26,920.00View SEC Filing  
6/24/2014Joseph E Turk JrPresidentSell3,950$14.43$56,998.50View SEC Filing  
6/20/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/17/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/9/2014Winifred L SwanSVPSell9,228$14.00$129,192.00View SEC Filing  
6/5/2014Jeffrey H BurbankCEOSell5,000$14.00$70,000.00View SEC Filing  
6/5/2014Joseph E Turk JrPresidentSell1,500$14.00$21,000.00View SEC Filing  
6/5/2014Winifred L SwanSVPSell7,500$14.00$105,000.00View SEC Filing  
5/29/2014Joseph E Turk JrPresidentSell4,035$13.60$54,876.00View SEC Filing  
5/15/2014Winifred SwanSVPSell9,629$12.80$123,251.20View SEC Filing  
5/14/2014Winifred SwanSVPSell5,000$13.04$65,200.00View SEC Filing  
3/6/2014Robert FunariDirectorBuy10,150$14.72$149,408.00View SEC Filing  
10/21/2013Robert S BrownInsiderSell140,100$14.00$1,961,400.00View SEC Filing  
9/9/2013Thomas SheaSVPSell1,000$12.30$12,300.00View SEC Filing  
8/12/2013Thomas SheaSVPSell1,172$12.93$15,153.96View SEC Filing  
7/8/2013Thomas SheaSVPSell7,000$14.34$100,380.00View SEC Filing  
6/10/2013Thomas SheaSVPSell5,000$13.73$68,650.00View SEC Filing  
5/13/2013Thomas SheaSVPSell15,724$12.67$199,223.08View SEC Filing  
11/13/2012David S UtterbergDirectorSell184,204$11.58$2,133,082.32View SEC Filing  
11/2/2012David S UtterbergDirectorSell34,730$11.13$386,544.90View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for NxStage Medical (NASDAQ:NXTM)
DateHeadline
News IconNxStage Medical, Inc. Announces First Quarter 2017 Investor Conference Schedule (NASDAQ:NXTM)
www.biospace.com - February 16 at 6:31 PM
finance.yahoo.com logoNxStage Announces First Quarter 2017 Investor Conference Schedule (NASDAQ:NXTM)
finance.yahoo.com - February 16 at 6:31 PM
finance.yahoo.com logoNxStage Announces First Quarter 2017 Investor Conference Schedule (NASDAQ:NXTM)
finance.yahoo.com - February 16 at 6:31 PM
News IconChecking the Numbers on Nxstage Medical, Inc. (NASDAQ:NXTM) - Midway Monitor (NASDAQ:NXTM)
midwaymonitor.com - February 14 at 10:15 PM
marketexclusive.com logoInsider Trading Activity NxStage Medical, Inc. (NASDAQ:NXTM ... - Market Exclusive (NASDAQ:NXTM)
marketexclusive.com - February 14 at 10:15 PM
247wallst.com logoTop Analyst Upgrades and Downgrades: Barracuda, Cabot, Calpine, Delta, FedEx, NVIDIA, US Steel and Many More (NASDAQ:NXTM)
247wallst.com - February 6 at 9:25 AM
streetinsider.com logoNxstage Medical (NXTM) Names Allan Collins to CMO - StreetInsider.com (NASDAQ:NXTM)
www.streetinsider.com - February 4 at 5:48 AM
streetinsider.com logoNxstage Medical (NXTM) Names Allan Collins to CMO (NASDAQ:NXTM)
www.streetinsider.com - February 3 at 7:47 PM
finance.yahoo.com logoNxStage Announces Appointment of Chief Medical Officer (NASDAQ:NXTM)
finance.yahoo.com - February 3 at 7:47 PM
finance.yahoo.com logo8:03 am Nxstage Medical appoints Allan Collins, M.D., FACP, as Chief Medical Officer (NASDAQ:NXTM)
finance.yahoo.com - February 3 at 7:47 PM
seekingalpha.com logoNxStage: Big Growth Opportunities Ahead (NASDAQ:NXTM)
seekingalpha.com - January 25 at 10:29 PM
capitalcube.com logoNxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : January 25, 2017 (NASDAQ:NXTM)
www.capitalcube.com - January 25 at 10:29 PM
News IconEarnings in Full Force, Analysts Take Aim at NxStage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - January 25 at 6:02 AM
News IconInvestor Update on Shares of Nxstage Medical Inc. (NXTM) - Springdale Times (NASDAQ:NXTM)
springdaletimes.com - January 22 at 11:49 PM
News IconWhat is the Sell-side Saying About NxStage Medical, Inc. (NASDAQ:NXTM)? - Aiken Advocate (NASDAQ:NXTM)
aikenadvocate.com - January 19 at 11:31 PM
capitalcube.com logoETFs with exposure to NxStage Medical, Inc. : January 19, 2017 (NASDAQ:NXTM)
www.capitalcube.com - January 19 at 11:31 PM
finance.yahoo.com logoNxStage® to Report Fourth Quarter and Full Year 2016 Financial Results (NASDAQ:NXTM)
finance.yahoo.com - January 16 at 7:28 PM
investornewswire.com logoNxStage Medical, Inc. (NASDAQ:NXTM) Records An Impact Score Of 82 - Investor Newswire (NASDAQ:NXTM)
www.investornewswire.com - January 15 at 6:33 PM
News IconStock Vaulting to Uncharted Territory: Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - January 13 at 12:38 AM
News IconCompany in Focus: Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - January 9 at 4:44 AM
finance.yahoo.com logoMasimo to Launch Advanced Monitoring Technologies in India (NASDAQ:NXTM)
finance.yahoo.com - January 3 at 10:28 AM
finance.yahoo.com logoIllumina Fettered With Losses: Can It Bounce Back in 2017? (NASDAQ:NXTM)
finance.yahoo.com - January 3 at 10:28 AM
us.rd.yahoo.com logoAbaxis (ABAX) Veterinary Prospects Bright: Should You Hold? (NASDAQ:NXTM)
us.rd.yahoo.com - January 2 at 9:02 AM
4-traders.com logoInvestor Focus: Watching Shares of Nxstage Medical, Inc (NASDAQ:NXTM)
www.4-traders.com - December 31 at 8:43 AM
investornewswire.com logoSentiments And Ratings Alert: NxStage Medical, Inc. (NASDAQ:NXTM) - Investor Newswire (NASDAQ:NXTM)
www.investornewswire.com - December 30 at 7:21 PM
News IconWatching Stock Levels for Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - December 30 at 7:21 PM
zacks.com logoNuVasive (NUVA) Wins MHLW Approval for XLIF Device Suite (NASDAQ:NXTM)
www.zacks.com - December 30 at 8:44 AM
live-pr.com logoNew Market Research Report: NxStage Medical, Inc. (NXTM) - Financial and Strategic SWOT Analysis Review (NASDAQ:NXTM)
www.live-pr.com - December 29 at 9:22 AM
us.rd.yahoo.com logoNutrisystem Declares Multi-Brand Marketing Approach for '17 (NASDAQ:NXTM)
us.rd.yahoo.com - December 29 at 9:22 AM
finance.yahoo.com logoMyriad Genetics' Unit Releases Favorable Data on Vectra DA (NASDAQ:NXTM)
finance.yahoo.com - December 28 at 9:57 AM
News IconBoston Scientific Down on Risks; Innovations Raise Hope - Yahoo Sports (NASDAQ:NXTM)
sports.yahoo.com - December 27 at 9:56 AM
News IconLooking at the Levels for Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - December 27 at 9:56 AM
finance.yahoo.com logo5 Efficient Stocks to Strengthen Your Portfolio (NASDAQ:NXTM)
finance.yahoo.com - December 27 at 9:56 AM
News IconStock Concentration on Shares of Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - December 23 at 7:07 PM
News IconTicker Tracker: Looking at Nxstage Medical Inc. (NXTM) - StockTalk Daily (NASDAQ:NXTM)
stocktalkdaily.com - December 22 at 12:49 AM
News IconInside the Numbers for Nxstage Medical, Inc. (NASDAQ:NXTM) - Wall Street Beacon (NASDAQ:NXTM)
wsbeacon.com - December 22 at 12:49 AM
finance.yahoo.com logoChemed (CHE): Roto-Rooter Solid, Reimbursement a Concern (NASDAQ:NXTM)
finance.yahoo.com - December 21 at 9:30 AM
finance.yahoo.com logoVWR Plagued by Headwinds, Solid Fundamentals Raise Hope (NASDAQ:NXTM)
finance.yahoo.com - December 21 at 9:30 AM
News IconMF Rank in Focus for Nxstage Medical, Inc. (NASDAQ:NXTM) - Business Daily Leader (NASDAQ:NXTM)
businessdailyleader.com - December 20 at 1:08 PM
News IconMF Rank in Focus for Nxstage Medical, Inc. (NASDAQ:NXTM) - Business Daily Leader (NASDAQ:NXTM)
businessdailyleader.com - December 20 at 1:08 PM
finance.yahoo.com logoCVS Health (CVS) Down on Prevailing Risks, Tepid Guidance (NASDAQ:NXTM)
finance.yahoo.com - December 20 at 1:08 PM
finance.yahoo.com logoAmedisys' Unit to Buy Personal Care Provider, Home Staff (NASDAQ:NXTM)
finance.yahoo.com - December 20 at 1:08 PM
finance.yahoo.com logoHologic (HOLX) to Divest Blood Screening Business to Grifols (NASDAQ:NXTM)
finance.yahoo.com - December 19 at 9:12 AM
finance.yahoo.com logoHill Rom Gains on Solid Q4, Buyouts & Product Launches (NASDAQ:NXTM)
finance.yahoo.com - December 19 at 9:12 AM
News IconChecking ROIC Numbers for Nxstage Medical, Inc. (NASDAQ:NXTM) - Liberty News (NASDAQ:NXTM)
libertynewsrecord.com - December 18 at 7:16 PM
investornewswire.com logoNxStage Medical, Inc. (NASDAQ:NXTM) Records An Impact Score Of 62 - Investor Newswire (NASDAQ:NXTM)
www.investornewswire.com - December 17 at 12:45 AM
News IconTechnical Review on Shares of Nxstage Medical Inc. (NXTM) - StockTalk Daily (NASDAQ:NXTM)
stocktalkdaily.com - December 17 at 12:45 AM
News IconChecking on Shares of Nxstage Medical, Inc. (NASDAQ:NXTM) - Business Daily Leader (NASDAQ:NXTM)
businessdailyleader.com - December 17 at 12:45 AM
marketexclusive.com logoAnalyst Activity – Northland Securities Raises Its Price Target On NxStage Medical (NASDAQ:NXTM) to (NASDAQ:NXTM)
marketexclusive.com - December 16 at 7:41 PM
News IconF-Score Review on Shares of Nxstage Medical, Inc. (NASDAQ:NXTM) - The Business Journal (NASDAQ:NXTM)
belmontbusinessjournal.com - December 15 at 7:52 PM

Social

What is NxStage Medical's stock symbol?

NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM."

Where is NxStage Medical's stock going? Where will NxStage Medical's stock price be in 2017?

6 analysts have issued 12 month price targets for NxStage Medical's shares. Their predictions range from $21.00 to $38.00. On average, they expect NxStage Medical's share price to reach $30.80 in the next year.

When will NxStage Medical announce their earnings?

NxStage Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February, 28th 2017.

What are analysts saying about NxStage Medical stock?

Here are some recent quotes from research analysts about NxStage Medical stock:

  • Jefferies Group LLC analysts commented, "Home hemodialysis (HHD) in skilled nursing facilities (SNF) is a significant opportunity for NXTM. HHD penetration is already approaching 6% in the most developed states v. less than 2% for the market as a whole; a disparity explained to a large degree by SNF adoption. The regulatory underpinnings can be debated, but even modest assumptions for continued adoption in SNFs supports 20%+ revenue growth at NXTM. We raise our PT to $38, 5x 2018 sales." (2/6/2017)
  • According to Zacks Investment Research, "NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. " (1/5/2017)

Who owns NxStage Medical stock?

NxStage Medical's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include FMR LLC (11.34%), Deerfield Management Co. (6.58%), Perceptive Advisors LLC (2.98%), Cortina Asset Management LLC (2.11%), State Street Corp (1.87%) and Arrowstreet Capital Limited Partnership (0.95%). Company insiders that own NxStage Medical stock include Barry M Straube, Craig W Moore, Daniel A Giannini, Earl R Lewis, Jeffrey H Burbank, Joseph E Turk Jr, Joseph E Turk, Jr, Matthew W Towse, Robert S Brown and Winifred L Swan.

Who sold NxStage Medical stock? Who is selling NxStage Medical stock?

NxStage Medical's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Renaissance Technologies LLC, Cortina Asset Management LLC, Employees Retirement System of Texas, Two Sigma Investments LP, Nicholas Investment Partners LP, Continental Advisors LLC and William Blair Investment Management LLC. Company insiders that have sold NxStage Medical stock in the last year include Craig W Moore, Daniel A Giannini, Jeffrey H Burbank, Joseph E Turk Jr, Matthew W Towse, Robert S Brown and Winifred L Swan.

Who bought NxStage Medical stock? Who is buying NxStage Medical stock?

NxStage Medical's stock was acquired by a variety of institutional investors in the last quarter, including Perceptive Advisors LLC, Marshall Wace LLP, Arrowstreet Capital Limited Partnership, Deerfield Management Co., Loomis Sayles & Co. L P, Advisory Research Inc., Elkfork Partners LLC and A.R.T. Advisors LLC. Company insiders that have bought NxStage Medical stock in the last two years include Barry M Straube and Earl R Lewis.

How do I buy NxStage Medical stock?

Shares of NxStage Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of NxStage Medical stock cost?

One share of NxStage Medical stock can currently be purchased for approximately $29.37.

NxStage Medical (NASDAQ:NXTM) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for NxStage Medical (NASDAQ:NXTM)

Earnings History Chart

Earnings by Quarter for NxStage Medical (NASDAQ:NXTM)

Dividend History Chart

Dividend Payments by Quarter for NxStage Medical (NASDAQ:NXTM)

Last Updated on 2/20/2017 by MarketBeat.com Staff